EXOME

all the information, none of the junk | biotech • healthcare • life sciences

$10M for Tetraphase

Watertown, MA-based Tetraphase Pharmaceuticals has raised $10 million out of a planned $29.6 million equity financing round, according to regulatory documents filed Wednesday. The Harvard spinoff, which is using synthetic chemistry to develop new antibiotics for drug-resistant infections, previously raised $25 million in two tranches that closed in August 2008.

By posting a comment, you agree to our terms and conditions.